Quince Therapeutics (QNCX) Short Interest Ratio & Short Volume → Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad) Free QNCX Stock Alerts $0.79 -0.05 (-5.95%) (As of 06/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Quince Therapeutics Short Interest DataCurrent Short Interest1,990,000 sharesPrevious Short Interest1,970,000 sharesChange Vs. Previous Month+1.02%Dollar Volume Sold Short$1.81 millionShort Interest Ratio22.6 Days to CoverLast Record DateMay 15, 2024Outstanding Shares43,220,000 sharesFloat Size32,270,000 sharesShort Percent of Float6.17%Today's Trading Volume330,746 sharesAverage Trading Volume88,551 sharesToday's Volume Vs. Average374% Short Selling Quince Therapeutics ? Sign up to receive the latest short interest report for Quince Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartQNCX Short Interest Over TimeQNCX Days to Cover Over TimeQNCX Percentage of Float Shorted Over Time Ad Paradigm PressTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.That will slam shut June 25. Quince Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,990,000 shares $1.81 million +1.0%6.2%22.6 $0.91 4/30/20241,970,000 shares $2.11 million +5.9%6.6%26.7 $1.07 4/15/20241,860,000 shares $1.87 million No Change6.2%26.8 $1.01 3/31/20241,860,000 shares $1.97 million No Change6.2%26.9 $1.06 3/15/20241,860,000 shares $2.16 million -2.1%6.3%26.4 $1.16 2/29/20241,900,000 shares $2.47 million No Change6.4%22.6 $1.30 Get the Latest News and Ratings for QNCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,900,000 shares $2.47 million No Change6.4%20.3 $1.30 1/31/20241,900,000 shares $2.36 million -7.3%6.0%20.9 $1.24 1/15/20242,050,000 shares $2.81 million -8.1%6.4%23.2 $1.37 12/31/20232,230,000 shares $2.34 million +16.2%6.9%29.1 $1.05 12/15/20231,920,000 shares $2.27 million -10.7%6.0%18.8 $1.18 11/30/20232,150,000 shares $1.91 million -1.4%6.2%23.2 $0.89 11/15/20232,180,000 shares $1.94 million +0.9%6.3%24 $0.89 10/31/20232,160,000 shares $2.10 million -8.1%6.5%20.3 $0.97 10/15/20232,350,000 shares $2.33 million +0.4%8.3%16.1 $0.99 9/30/20232,340,000 shares $2.62 million -2.1%8.2%7.7 $1.12 9/15/20232,390,000 shares $2.99 million -1.7%8.5%8.6 $1.25 8/31/20232,430,000 shares $3.18 million -6.5%8.6%8.7 $1.31 8/15/20232,600,000 shares $3.30 million -9.7%9.2%9.3 $1.27 7/31/20232,880,000 shares $3.46 million -10.8%10.0%10.5 $1.20 7/15/20233,230,000 shares $5.26 million No Change11.5%12.3 $1.63 6/30/20233,230,000 shares $4.86 million -0.9%11.3%23.8 $1.51 6/15/20233,260,000 shares $4.89 million +2.5%11.4%15.3 $1.50 5/31/20233,180,000 shares $4.77 million +5.3%11.1%2.9 $1.50 5/15/20233,020,000 shares $4.65 million No Change10.6%2.7 $1.54 QNCX Short Interest - Frequently Asked Questions What is Quince Therapeutics' current short interest? Short interest is the volume of Quince Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 1,990,000 shares of QNCX short. 6.17% of Quince Therapeutics' shares are currently sold short. Learn More on Quince Therapeutics' current short interest. What is a good short interest ratio for Quince Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. QNCX shares currently have a short interest ratio of 23.0. Learn More on Quince Therapeutics's short interest ratio. What is a good short interest percentage for Quince Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.17% of Quince Therapeutics' floating shares are currently sold short. Is Quince Therapeutics' short interest increasing or decreasing? Quince Therapeutics saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 1,990,000 shares, an increase of 1.0% from the previous total of 1,970,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Quince Therapeutics' float size? Quince Therapeutics currently has issued a total of 43,220,000 shares. Some of Quince Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Quince Therapeutics currently has a public float of 32,270,000 shares. How does Quince Therapeutics' short interest compare to its competitors? 6.17% of Quince Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Quince Therapeutics: Verastem, Inc. (3.94%), Vistagen Therapeutics, Inc. (4.36%), Opthea Limited (0.19%), Cellectis S.A. (0.92%), Molecular Partners AG (0.14%), Vaxart, Inc. (10.52%), Cardiff Oncology, Inc. (10.33%), aTyr Pharma, Inc. (0.50%), Sangamo Therapeutics, Inc. (7.10%), DBV Technologies S.A. (0.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Quince Therapeutics stock? Short selling QNCX is an investing strategy that aims to generate trading profit from Quince Therapeutics as its price is falling. QNCX shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Quince Therapeutics? A short squeeze for Quince Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of QNCX, which in turn drives the price of the stock up even further. How often is Quince Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QNCX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: VSTM Short Interest Data VTGN Short Interest Data OPT Short Interest Data CLLS Short Interest Data MOLN Short Interest Data VXRT Short Interest Data CRDF Short Interest Data LIFE Short Interest Data SGMO Short Interest Data DBVT Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:QNCX) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quince Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quince Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.